| Accession | HRS343575 |
|---|---|
| BioSample Accession | SAMC2054202 |
| Individual accession | HRI195722 |
| Study accession | HRA002026 |
| Sample name | 44_6 |
| Sample title | HeLa G1/S CDK2i-3 |
| Collection date | 2020-12-04 |
| Sample Type | Cell line |
| Description | RNA-Seq sample3 of HeLa cell after treated with CDK2 inhibitor (SB1317) in G1/S phase |
| Tissue | cervical adenocarcinoma cell line |
| Release date | 2022-02-25 |